ArticleTranslational lung cancer research2022

PD-1/PD-L1 inhibitor activity in patients with gene-rearrangement positive non-small cell lung cancer-an IMMUNOTARGET case series.

Rao Mushtaq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.